Envoy Medical (COCH) Gross Margin (2022 - 2026)

Envoy Medical has disclosed Gross Margin across 5 years of filings, most recently posting 445.1% for Q2 2026.

• In Q2 2026, Gross Margin fell 24510.0% year-over-year to 445.1%; the TTM figure through Jun 2026 stood at 385.51% (down 12335.0% YoY), while the FY2025 annual figure was 262.66%, down 3288.0% from the prior year.
• Gross Margin came in at 445.1% for Q2 2026 at Envoy Medical, up from 702.56% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 85.96% in Q3 2022 to a low of 702.56% in Q1 2026.
• Average Gross Margin over 5 years is 283.5%, with a median of 216.96% recorded in 2024.
• Year-over-year, Gross Margin surged 50868 bps in 2023 and sank 31126 bps in 2026.
• Over 5 years, Gross Margin stood at 655.0% in 2022, then jumped by 78 bps to 146.32% in 2023, then plunged by 87 bps to 273.81% in 2024, then jumped by 34 bps to 181.33% in 2025, then tumbled by 145 bps to 445.1% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 445.1% in Q2 2026, 702.56% in Q1 2026, and 181.33% in Q4 2025.